Balkrishna Industries Board to Consider Interim Dividend on October 31
The Board of Directors of Balkrishna Industries is scheduled to meet on October 31, 2025, to consider and approve the unaudited financial…
K.P.R. Mill Board Meeting to Discuss Un-Audited Financial Results
K.P.R. Mill Limited has announced a board meeting to discuss the un-audited financial results for the quarter and half-year ended September…
ALKEM Laboratories Board to Consider Unaudited Financial Results on November 13, 2025
ALKEM Laboratories has announced that a meeting of the Board of Directors is scheduled for November 13th, 2025. The board will consider and…
Colgate-Palmolive Q2 FY’26 Sales Decline, Interim Dividend Declared
Colgate-Palmolive (India) Limited reported a 6.3% year-over-year decline in net sales for Q2 FY’26, though sales increased 6.1%…
Laurus Labs Interim Dividend Declared; Revenue Jumps in Q2 2026
Laurus Labs has reported a robust financial performance for Q2 2026, with revenue from operations reaching ₹1,653.47 crore. The Board has…
Bank of Baroda Board to Approve Q2 Financial Results October 31, 2025
Bank of Baroda will hold a board meeting on Friday, October 31, 2025, to consider and approve the Un-audited (Reviewed) Standalone &…
Indegene Limited Board to Consider Quarterly Results on October 30, 2025
Indegene Limited has announced a board meeting scheduled for October 30, 2025, to review and approve the unaudited consolidated and standalone…
Garden Reach Board to Consider Interim Dividend on November 4, 2025
The Board of Directors of Garden Reach Shipbuilders & Engineers is scheduled to meet on November 4, 2025, to consider and approve the…
RailTel Board to Consider Interim Dividend on October 29, 2025
RailTel has announced a board meeting scheduled for October 29, 2025, to consider and approve the unaudited financial results for the quarter…
Alembic Pharmaceuticals Board to Consider Unaudited Financial Results
Alembic Pharmaceuticals has announced that its Board of Directors will convene on Tuesday, November 4, 2025, to review and approve the…